000			01589 a2200433 4500
005			20250518062406.0
264		0	_c20200323
008			202003s 0 0 eng d
022			_a2363-8915
024	7		_a10.1515/dmpt-2018-0039 _2doi
040			_aNLM _beng _cNLM
100	1		_aMirzaev, Karin B
245	0	0	_aEffects of the rs2244613 polymorphism of the CES1 gene on the antiplatelet effect of the receptor P2Y12 blocker clopidogrel. _h[electronic resource]
260			_bDrug metabolism and personalized therapy _c09 2019
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAcute Coronary Syndrome _xdiagnosis
650	0	4	_aAdult
650	0	4	_aCarboxylic Ester Hydrolases _xblood
650	0	4	_aClopidogrel _xpharmacology
650	0	4	_aFemale
650	0	4	_aGenotype
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPlatelet Aggregation _xdrug effects
650	0	4	_aPlatelet Aggregation Inhibitors _xpharmacology
650	0	4	_aPolymorphism, Genetic _xgenetics
650	0	4	_aPurinergic P2Y Receptor Antagonists _xpharmacology
650	0	4	_aReceptors, Purinergic P2Y12 _xmetabolism
700	1		_aOsipova, Darya V
700	1		_aKitaeva, Elena J
700	1		_aShprakh, Vladimir V
700	1		_aAbdullaev, Sherzod P
700	1		_aAndreev, Denis A
700	1		_aMumladze, Robert B
700	1		_aSychev, Dmitriy A
773	0		_tDrug metabolism and personalized therapy _gvol. 34 _gno. 3
856	4	0	_uhttps://doi.org/10.1515/dmpt-2018-0039 _zAvailable from publisher's website
999			_c30150850 _d30150850